Girard Sandrine, Berda-Haddad Yaël, Brouzes Chantal, Badaoui Bouchra, Boussaroque Agathe, Janel Alexandre, Chatelain Bernard, Baccini Véronique
Haematology Biology, Hospices Civils de Lyon, Lyon, France.
Haematology Biology, University Hospital Timone, AP-HM, Marseille, France.
Int J Lab Hematol. 2025 Oct;47(5):798-807. doi: 10.1111/ijlh.14536. Epub 2025 Aug 17.
Mean corpuscular haemoglobin concentration (MCHC) is determined by the ratio of haemoglobin concentration to haematocrit. Managing increased MCHC presents significant challenges, mainly due to variations in analytical methods and pathophysiological conditions. Depending on the haematological analyser (HA), MCHC can be measured directly or calculated. It is important that all people involved in hematocytometry must identify and correct artefacts to ensure accurate erythrocyte parameters. In order to harmonise and standardise haematology practices in all laboratories, the French-speaking Cellular Haematology Group (GFHC) has reviewed the interferences and pathophysiological situations that could increase MCHC, and the advice on how to manage cases of elevated MCHC. We will review current techniques, such as impedance and optical methods, for accurate determination of MCHC. We will also examine the interferences that can artificially increase MCHC; and the pathophysiological conditions responsible for such increases. Finally, we will present guidelines for the management of elevated MCHC, including strategies to bypass interferences and determine which erythrocyte parameters can be reliably reported, as well as the acceptable MCHC values for various pathophysiological variations.
平均红细胞血红蛋白浓度(MCHC)由血红蛋白浓度与血细胞比容的比值决定。处理升高的MCHC存在重大挑战,主要是由于分析方法和病理生理状况的差异。根据血液分析仪(HA)的不同,MCHC可以直接测量或计算得出。所有参与血细胞计数的人员必须识别并纠正假象,以确保红细胞参数的准确性,这一点很重要。为了使所有实验室的血液学实践协调一致并标准化,说法语的细胞血液学小组(GFHC)审查了可能增加MCHC的干扰因素和病理生理状况,以及处理MCHC升高病例的建议。我们将回顾当前用于准确测定MCHC的技术,如阻抗法和光学方法。我们还将研究可人为增加MCHC的干扰因素,以及导致此类升高的病理生理状况。最后,我们将提出处理MCHC升高的指南,包括绕过干扰因素的策略、确定哪些红细胞参数可以可靠报告,以及各种病理生理变化的可接受MCHC值。